Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

aTyr Pharma Inc (NASDAQ:LIFE)

17.64
Delayed Data
As of 3:59pm ET
 -1.27 / -6.72%
Today’s Change
12.90
Today|||52-Week Range
28.29
-63.05%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 42.00, with a high estimate of 44.00 and a low estimate of 32.00. The median estimate represents a +138.10% increase from the last price of 17.64.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in aTyr Pharma Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.51
Sales
$0.00
Reporting Date
Sep 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 94.56%
 
 
 
Growthannually 36.09%
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.